1989
DOI: 10.1016/0168-3659(89)90023-0
|View full text |Cite
|
Sign up to set email alerts
|

Polymer derivatives of β-lactam antibiotics of the penicillin series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

1993
1993
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…13,22−24 These rare examples show that the polymer antibiotic conjugates (PACs) reveal a higher activity, 25 efficiency against biofilms 26,27 or more stability. 24 This shows the potential of such polymer antibiotic conjugates. In most cases, the antibiotics were used as backbone modification or as end groups for hyperbranched polymers and dendrimers.…”
Section: ■ Introductionmentioning
confidence: 87%
See 1 more Smart Citation
“…13,22−24 These rare examples show that the polymer antibiotic conjugates (PACs) reveal a higher activity, 25 efficiency against biofilms 26,27 or more stability. 24 This shows the potential of such polymer antibiotic conjugates. In most cases, the antibiotics were used as backbone modification or as end groups for hyperbranched polymers and dendrimers.…”
Section: ■ Introductionmentioning
confidence: 87%
“…One rarely followed approach is the derivatization of established antibiotics with polymers to change their activity profile and, possibly, their resistance-forming potential. These are usually release systems. The covalent conjugation is used for biocides but less frequently for antibiotics, e.g., penicillin. , These rare examples show that the polymer antibiotic conjugates (PACs) reveal a higher activity, efficiency against biofilms , or more stability . This shows the potential of such polymer antibiotic conjugates.…”
Section: Introductionmentioning
confidence: 99%
“…Most permanent PACs contain antibiotics such as doxorubicin because of their anticancer properties. , Permanent PACs which focus on the treatment of bacterial infections are rarely considered. The few known examples show that PACs can exhibit higher activity and higher efficiency against biofilms and become more stable . In previous work, we presented the conjugation of ciprofloxacin (CIP) and penicillin with poly­(2-oxazoline) (POx) via end group modification.…”
Section: Introductionmentioning
confidence: 99%
“…The few known examples show that PACs can exhibit higher activity 21 and higher efficiency against biofilms 22 and become more stable. 23 In previous work, we presented the conjugation of ciprofloxacin (CIP) 24 and penicillin 25 with poly(2-oxazoline) (POx) via end group modification. In the case of penicillin, the conjugates exhibit a high resistance against the hydrolysis caused by penicillinase and are thus more active against typical penicillinresistant strains.…”
Section: ■ Introductionmentioning
confidence: 99%
“…[28][29][30][31][32] To overcome the limitations associated with physical admixture and pendant attachment methods, and to better control the release characteristics of antimicrobial-eluting polymer systems, methods to chemically incorporate bioactives within the polymer backbone are being investigated. [33][34][35][36] In this study, a novel, degradable biomaterial was designed to release antimicrobials upon polymer degradation and thus locally prevent infections during the first few hours following surgery, when the implant is most susceptible to bacterial colonization. 37 The synthesis and physicochemical characterization of an ampicillin analog or prodrug, as well as chemical incorporation into a polyanhydride backbone, are described.…”
Section: Introductionmentioning
confidence: 99%